| Literature DB >> 35301071 |
Bedowra Zabeen1, Bulbul Ahmed2, Jebun Nahar2, Samin Tayyeb3, Nasreen Islam2, Fauzia Mohsin2, Kishwar Azad3.
Abstract
OBJECTIVE: Muslim people with T1DM should be actively discouraged from fasting during the COVID-19 pandemic, as diabetes has emerged as a significant risk factor for adverse outcomes of COVID-19 infection. We report the experience of young patients with type 1, type 2 and other types diabetes who fasted during Ramadan 2020 at the time of the COVID-19 pandemic time lockdown. RESEARCH DESIGN AND METHODS: A Post- Ramadan survey was designed for young patients who fasted during Ramadan in 2020 during COVID pandemic time. The study was conducted to compared the basal characteristics and other parameters in children and adolescents (<18 years), with young adults (≥18 years) with diabetes at Paediatric Diabetes Center in BIRDEM in Bangladesh.Entities:
Keywords: COVID-19; Diabetes; Fasting; Pandemic lock down; Ramadan
Mesh:
Substances:
Year: 2022 PMID: 35301071 PMCID: PMC8920591 DOI: 10.1016/j.diabres.2022.109812
Source DB: PubMed Journal: Diabetes Res Clin Pract ISSN: 0168-8227 Impact factor: 8.180
Comparison of Basal characteristics between two groups.
| Characteristics | Age group < 18 years | Age group ≥ 18 years | P value |
|---|---|---|---|
| Area | |||
| Age at Diagnosis | 12.0[9.7–14.0] | 13.0[12.0–15.0] | 0.0001 |
| Current age (years) | 16.0[14.0–17.5] | 22.0[20.0–24.0] | 0.0001 |
| Gender | |||
| Male (%) | 44 (43.1%) | 90 (45.5%) | |
| Female (%) | 58 (56.9%) | 108(54.5%) | 0.702 |
| Duration of diabetes | 4.0[ 2.0–6.0] | 9.0[7.0–11.0] | 0.0001 |
| Types of diabetes | |||
| Type 1 (n = 211) | 75 | 136 | |
| Type 2 (n = 63) | 23 | 40 | |
| Other types (n = 26) | 4 | 22 | 0.110 |
| SMBG done | |||
| Yes (n = 102) | 54 (28.9%) | 48 (42.5%) | |
| No (n = 198) | 133 (71.1%) | 65 (57.5%) | 0.016 |
| Basal dose | 24.0[19.5–32.0] | 30.0[21.5–38.0] | 0.001 |
| Bolus dose | 28.0[15.5–36.0] | 34.0[21.5–46.0] | 0.004 |
| TDD | 53.0[34.0–68.0] | 64.0[44.0–84.0] | 0.002 |
| Median HbA1c | 8.4[7.2–9.8] | 7.9[7.1–9.0] | 0.135 |
Fig 1Comparison of fasting days between two groups.
Fig 2Incidence of hypoglycaemia between two groups.
Fig 3Incidence of hyperglycaemia and normoglycaemia between two groups.
Comparison of Post Ramadan basal and bolus doses and HbA1c between two groups.
| Parameters | <18 years | ≥18 years | P value |
|---|---|---|---|
| Basal dose | 20.0[4.0–26.0] | 24.0[13.0–32.0] | 0.001 |
| Bolus dose | 16.0[4.0–22.0] | 53.0[ 37.5–70.0 | 0.001 |
| TDD | 53.0[37.5–70.0 | 62.0[43.0–84.0] | 0.009 |
| Median HbA1c | 8.6[7.8–9.7] | 8.5[7.7–9.4] | 0.239 |
Fig. 4Comparison of HbA1c at Post Ramadan time in between two groups p = 0.569.